TOPIC

healthcare

HOYA CORPORATIONYear ended March 2026

What semiconductors and HDDs require of HOYA’s glass.

¥947.7bnRevenue for the year ended March 2026
62% / 38%Life Care / Information Technology revenue mix
~¥92bnPlanned Phase 1 investment in EUV + HDD plants
What emerges

HOYA’s mask blanks enter semiconductor circuit-patterning processes; its HDD glass substrates become the bases of magnetic disks. The company emphasizes customer-specific technical alignment in the first business and consistent high-volume production in the second. Revenue was ¥947.7bn in the year ended March 2026, with a company-reported mix of 62% Life Care and 38% Information Technology. Supplying lenses to optical retailers and operating Eyecity stores are also important parts of the group. Initial-phase investment in two new EUV and HDD plants is planned at roughly ¥92bn combined. Looking at customer processes and supply requirements helps explain the strengths of the businesses that expanded from optical glass.

See the company through the numbers →
富士フイルムホールディングス株式会社Year ended March 2026

Taking stock of photographic technology: Fujifilm finds new uses.

18.7%Imaging share of group revenue (site calculation)
¥1.099tnHealthcare revenue
12 / 16 equivalentU.S. bioreactor-capacity equivalent sold before operation (including informal agreements)
What emerges

Fujifilm combines technologies developed for photography with acquired businesses and manufacturing capacity. Alongside office and printing products, medical systems, photography and semiconductor materials, its Bio CDMO develops and manufactures drugs for pharmaceutical customers. The 12/16 U.S. figure describes capacity covered by contracts and informal agreements on planned manufacturing volumes, rather than sales of manufacturing equipment.

See the company through the numbers →